Melani C - Search Results

1

TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.

Sommariva M, De Cecco L, De Cesare M, Sfondrini L, Ménard S, Melani C, Delia D, Zaffaroni N, Pratesi G, Uva V, Tagliabue E, Balsari A. Sommariva M, et al. Among authors: melani c. Cancer Res. 2011 Oct 15;71(20):6382-90. doi: 10.1158/0008-5472.CAN-11-1285. Epub 2011 Aug 30. Cancer Res. 2011. PMID: 21878529

2

An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines.

Melani C, Pupa SM, Stoppacciaro A, Ménard S, Colnaghi MI, Parmiani G, Colombo MP. Melani C, et al. Int J Cancer. 1995 Sep 4;62(5):572-8. doi: 10.1002/ijc.2910620514. Int J Cancer. 1995. PMID: 7665228

3

Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38-kDa antigen.

Sfondrini L, Morelli D, Ménard S, Maier J, Singh M, Melani C, Terrazzini N, Colombo M, Colnaghi M, Balsari A. Sfondrini L, et al. Among authors: melani c. Gene Ther. 1998 Feb;5(2):247-52. doi: 10.1038/sj.gt.3300575. Gene Ther. 1998. PMID: 9578845

4

Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells.

Tagliabue E, Castiglioni F, Ghirelli C, Modugno M, Asnaghi L, Somenzi G, Melani C, Ménard S. Tagliabue E, et al. Among authors: melani c. J Biol Chem. 2000 Feb 25;275(8):5388-94. doi: 10.1074/jbc.275.8.5388. J Biol Chem. 2000. PMID: 10681513 Free article.

5

Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells.

Vagliani M, Rodolfo M, Cavallo F, Parenza M, Melani C, Parmiani G, Forni G, Colombo MP. Vagliani M, et al. Among authors: melani c. Cancer Res. 1996 Feb 1;56(3):467-70. Cancer Res. 1996. PMID: 8564954

6

Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.

Melani C, Rivoltini L, Parmiani G, Calabretta B, Colombo MP. Melani C, et al. Cancer Res. 1991 Jun 1;51(11):2897-901. Cancer Res. 1991. PMID: 2032228

7

Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70.

Massa C, Guiducci C, Arioli I, Parenza M, Colombo MP, Melani C. Massa C, et al. Among authors: melani c. Cancer Res. 2004 Feb 15;64(4):1502-8. doi: 10.1158/0008-5472.can-03-2936. Cancer Res. 2004. PMID: 14973071

8

Amount of interleukin 12 available at the tumor site is critical for tumor regression.

Colombo MP, Vagliani M, Spreafico F, Parenza M, Chiodoni C, Melani C, Stoppacciaro A. Colombo MP, et al. Among authors: melani c. Cancer Res. 1996 Jun 1;56(11):2531-4. Cancer Res. 1996. PMID: 8653692

9

Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.

Melani C, Figini M, Nicosia D, Luison E, Ramakrishna V, Casorati G, Parmiani G, Eshhar Z, Canevari S, Colombo MP. Melani C, et al. Cancer Res. 1998 Sep 15;58(18):4146-54. Cancer Res. 1998. PMID: 9751627

10

IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases.

Rodolfo M, Melani C, Zilocchi C, Cappetti B, Luison E, Arioli I, Parenza M, Canevari S, Colombo MP. Rodolfo M, et al. Among authors: melani c. Cancer Res. 1998 Dec 15;58(24):5812-7. Cancer Res. 1998. PMID: 9865740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters